Basic principles in generating induced pluripotent stem cells
K. Sidhu, University of New South Wales, Australia
Abstract:
Induced pluripotent stem cell (iPSC) technology has potential in cell replacement therapy for patients suffering with Alzheimer’s, Parkinson’s, Type 1 diabetes and other cellular diseases. Somatic cell nuclear transfer (SCNT) technology laid the foundation for induced pluripotent stem cell technology. So far SCNT remains technically challenging and has low success rate particularly in humans because of ethical constraints. The iPSC technology brought the paradigm shift and took the debate away from SCNT because of ethical concerns. However, to harness the full potential of this technology, a number of issues still ...
Get Progenitor and Stem Cell Technologies and Therapies now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
